October 30, 2017
Data from the SysteMS pilot study, a collaboration between Brigham and Women’s Hospital, Verily and Biogen exploring the use of biosensors as a measure of MS disease severity, were presented today at MSParis2017, the seventh Joint Meeting of the European Committee for Treatment and Research in MS and Americas Committee […]
